Biotage AB (publ)'s latest marketcap:
As of 07/23/2025, Biotage AB (publ)'s market capitalization has reached $1.2 B. According to our data, Biotage AB (publ) is the 9209th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.2 B |
| Revenue (ttm) | 204.72 M |
| Net Income (ttm) | 26.62 M |
| Shares Out | 0 |
| EPS (ttm) | 0.33 |
| Forward PE | 59.66 |
| Ex-Dividend Date | 04/25/2025 |
| Earnings Date | 08/06/2025 |
Biotage AB (publ)'s yearly market capitalization.
| Date | Market Cap(£) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/23/2025 | £887.83 M | $1.2 B | -4.67% | 9209 |
| 12/30/2024 | £931.32 M | $1.17 B | 11.84% | 7971 |
| 12/29/2023 | £832.69 M | $1.06 B | -14.56% | 8346 |
| 12/30/2022 | £974.53 M | $1.18 B | -31.18% | 7488 |
| 12/30/2021 | £1.42 B | $1.91 B | 74.07% | 6300 |
| 12/30/2020 | £813.48 M | $1.11 B | 23.19% | 7504 |
| 12/30/2019 | £660.33 M | $875.59 M | 6.53% | 7405 |
| 12/28/2018 | £619.84 M | $790.3 M | 26.16% | 7005 |
| 12/29/2017 | £491.33 M | $663.34 M | 85.38% | 9052 |
| 12/30/2016 | £265.04 M | $327.21 M | 108.34% | 10903 |
Company Profile
About Biotage AB (publ)
Biotage AB (publ) is a leading provider of innovative solutions and products for drug discovery, analytical testing, and environmental analysis. The company serves a diverse range of industries with cutting-edge technologies designed to enhance efficiency and accuracy in research and testing.
Product Offerings
- Drug Discovery & Development: Organic and peptide synthesis solutions, flash chromatography systems, purification products, and reagents.
- Analytical Testing: Sample preparation solutions for clinical, forensic, environmental, and food safety applications.
- Biomolecule Purification: Antibody, plasmid, AAV, and tagged protein purification systems.
- Automation & Workflow Solutions: Custom automation systems and consumables for streamlined laboratory processes.
- Environmental Testing: Advanced tools for water and environmental analysis.
Industries Served
Biotage caters to a broad clientele, including:
- Pharmaceutical and biotech companies
- Contract research and manufacturing organizations
- Academic and clinical laboratories
- Forensic and environmental agencies
- Food safety and sports testing organizations
Global Presence
With operations spanning the Americas, Asia-Pacific, Europe, the Middle East, and Africa, Biotage ensures worldwide accessibility to its solutions.
Founded: 1969 | Headquarters: Uppsala, Sweden
Frequently Asked Questions
-
What is Biotage AB (publ)'s (LON-0GRP) current market cap?As of 07/23/2025, Biotage AB (publ) (including the parent company, if applicable) has an estimated market capitalization of $1.2 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Biotage AB (publ) (LON-0GRP) rank globally by market cap?Biotage AB (publ) global market capitalization ranking is approximately 9209 as of 07/23/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.